Validation of French Version of LCADL and Dyspnea-12

Copd Clinical Trial

— LCADL  

Official title:

Validation of the French Version of the London Chest Activity of Daily Living Scale (LCADL) and the Dyspnea-12 Questionnaire

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02555202
• Other study ID #: LCADL (RB 15.037)
• Status: Completed
• Phase: N/A
• First received: September 16, 2015
• Last updated: March 30, 2017
• Start date: October 15, 2015
• Est. completion date: September 30, 2016

Study information

• Verified date: September 2016
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The main objective of this study is to develop and to validate a French version of the London Chest Activity of Daily Living (LCADL) and the Dyspnea 12 and to determine the reliability of this version for the evaluation of the dyspnea in the Activity of Daily Living in COPD patients (stages severe and very severe).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: September 30, 2016
• Est. primary completion date: September 30, 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• COPD with FEV1< 50% of predictive value

Exclusion Criteria:

• FEV1> 50% of predictive value

• Patients with an exacerbation of COPD in the previous 30 days the inclusion

Related Conditions & MeSH terms

• Copd
• Dyspnea

Locations

Country	Name	City	State
France	Brest University hospital	Morlaix

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the Saint-Georges questionnaire, item Activity	by comparison with item activities of the Saint-Georges questionnaire for the LCADL	15 days
Primary	MMRC Dyspnea scale	by comparison with MMRC dyspnea scale for the dyspnea 12	15 days